AI for Science， Reshaping the underlying logic of drug discovery. From antibody design to wet experiment validation, from algorithm driven to data closed-loop, AI is no longer just icing on the cake, but has become the core variable that determines research and development efficiency and success or failure. The complete schedule of the "Intelligent Research Future AI for Life Science and Drug Discovery Special Session" co organized by MegaTech has been released. The special session will gather cutting-edge practitioners in the field of AI pharmaceuticals, focusing on the underlying computing power, data, and model infrastructure, the real industrialization practice of pharmaceutical companies and CROs, and the long-term development pattern for in-depth dialogue, jointly seeking a new research and development paradigm that integrates models, data, computing power, and scenarios.

Don't talk about concepts, only talk about practical situations. From July 22nd to 24th, at the Shanghai National Convention and Exhibition Center, we will explore the new paradigm of AI driven drug discovery with pioneers in AI pharmaceuticals.

25% off for the last 8 days! Sign up now!

Special Session Schedule
 

Session Co-organized by: MegaRobo、Huawei

Special Session Planning
Marks Zhang：Co-founder& SVP, MegaRobo Technologies
Xuan Xian：Partner & CAIO,TYK medicines

09:00-09:05　Opening Remarks
Marks Zhang：Co-founder& SVP, MegaRobo Technologies        

09:05-09:20　Building an Ecosystem for AI-enabled Pharmaceutical R&D
Michael Fanjie：President, Pharmaceutical BU, Huawei

09:20-09:35　Tianqiong: Data Infrastructure for AI for Science
Zhixiang Ren：Chief AI Scientist,  SmartLogic Tech

09:35-09:50　Extreme compression and reconstruction of the protein fitness landscape
Shuyi Zhang：Associate Professor, Tsinghua University School of Pharmaceutical Sciences

09:50-10:05　AI Scientist Agent-Driven Biologics R&D
Yuguang Wang：Founder & CEO, Toursynbio

10:05-10:20　New Infrastructure for AI-driven Novel Drug R&D
Peifeng Tang：CTO, MegaRobo Technologies

10:20-10:40　MegaRobo × LePure Joint New Product Launch

10:40-10:55　Wet-lab Data Acquisition for Rapid Iteration of AI-powered Macromolecular Drugs
Lei Shi：SVP, Biointron

10:55-11:10　How to Build an AI-native Biotech in One Year
Xuan Xian：Partner & CAIO,TYK medicines

11:10-12:00　The Next Frontier of AI-Driven Drug R&D: Models, Data, Compute & Scenarios — How to Assemble True Pharmaceutical Superintelligence?
Marks Zhang（How to Build an AI-native Biotech in One Year）：Co-founder & SVP, MegaRobo Technologies
Xuan Xian：Partner & CAIO,TYK medicines
Huaxing Zhu：Chairman, NOVOPROTEIN
Yunlong Song：Founder & CEO, Shanghai Cloudthera Bioscience Ltd
Xiaobing Li：Partner & Vice President, Wecomput
Jerry Xing：Co-founder & COO, PHARMOLIX